v3.25.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Total revenue $ 5,392 $ 6,471
Operating expenses:    
Research and development 36,442 38,065
General and administrative 11,480 10,661
Total operating expenses 47,922 48,726
Loss from operations (42,530) (42,255)
Other income:    
Interest income 1,614 2,197
Other income, net 1,074 2,184
Total other income, net 2,688 4,381
Loss before income taxes (39,842) (37,874)
Provision for income taxes (34) (40)
Net loss $ (39,876) $ (37,914)
Net loss per common share - basic $ (0.36) $ (0.35)
Net loss per common share - diluted $ (0.36) $ (0.35)
Weighted average number of common shares outstanding - basic 110,301,256 108,171,463
Weighted average number of common shares outstanding - diluted 110,301,256 108,171,463
Net loss $ (39,876) $ (37,914)
Other comprehensive income (loss):    
Unrealized loss on marketable securities (142) (443)
Comprehensive loss (40,018) (38,357)
Collaboration Revenue [Member]    
Total revenue $ 5,392 $ 6,471